Despite the common myth, alcohol and narcotics are the least effective means to spark creativity, researchers report. Instead, complex training, meditation, and cultural exposure add a boost to your creative flow.
It can take nine months or more for people who have used antidepressants for a long term to find relief from withdrawal symptoms. Researchers address the common symptoms of antidepressant withdrawal and steps to take to help improve symptoms.
Melatonin reduces self-harm in young people with depression and anxiety. The effects were more pronounced in females with anxiety and depression.
The psychedelic compound DMT (Dimethyltryptamine) increases connectivity across the brain, allowing for greater communication between different areas and networks. The brain changes are most prominent in brain areas linked to higher functioning, such as imagination.
Memantine, a drug commonly prescribed to treat symptoms of Alzheimer's disease, reduces symptoms for adults with hair-pulling and skin-picking disorders.
During the COVID-19 pandemic, there has been an uptick in the use of antidepressant medications to combat symptoms of depression. Researchers discuss the impact of antidepressant usage and provide guidelines for safe and effective withdrawal from antidepressant medications.
In addition to helping treat mental health disorders, psychedelic treatments can help people overcome addictions. A new study reports psychedelics can help smokers quit nicotine and remain smoke-free for at least five years.
Recent studies have explored the use of psychedelics for the treatment of a range of mental health disorders. A new study reveals more insightful and mystical "trips" while exposed to psychedelics may be linked to an enduring reduction of symptoms for those with anxiety and depression.
Prazosin, an FDA-approved medication for the treatment of hypertension may help to prevent relapse in people with cardiovascular and behavioral symptoms of alcohol withdrawal, a new study reports.
Apremilast, an FDA-approved drug for the treatment of skin conditions including psoriasis and psoriatic arthritis, triggers increased activity in the nucleus accumbens, a brain area associated with regulating alcohol intake. Apremilast reduced drinking behaviors in mouse models with a genetic risk of alcohol use disorder.
Those with cocaine use disorder who were administered ketamine for depression or pain experienced two-to-four times higher remission rate.
Vasodilators such as fasudil, commonly used for the treatment of stroke, restored pyramidal neurons in the prefrontal cortex of mouse models of schizophrenia associated with genetics.
